{{Rsnum
|rsid=32566
|Chromosome=5
|position=5792394
|Orientation=plus
|GMAF=0.2603
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 51.3 | 38.1 | 10.6
| HCB | 66.4 | 30.7 | 2.9
| JPT | 71.7 | 26.5 | 1.8
| YRI | 64.6 | 31.3 | 4.1
| ASW | 59.6 | 38.6 | 1.8
| CHB | 66.4 | 30.7 | 2.9
| CHD | 67.9 | 25.7 | 6.4
| GIH | 51.5 | 42.6 | 5.9
| LWK | 52.7 | 39.1 | 8.2
| MEX | 27.6 | 56.9 | 15.5
| MKK | 72.4 | 24.4 | 3.2
| TSI | 56.9 | 38.2 | 4.9
| HapMapRevision=28
}}

{{GWAS Summary
|SNP=rs32566
|PubMedID=17903295
|Condition=Morbidity-free survival
|Gene=Intergenic
|Risk Allele=
|pValue=2.00E-009
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs32566
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:17903295; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genetic correlates of longevity and selected age-related phenotypes: a genome-wide association study in the Framingham Study. (Initial Sample Size: 1,345 individuals (Framingham); Replication Sample Size: NR). This variant is associated with Morbidity-free survival.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356447
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs32566
|overall_frequency_n=43
|overall_frequency_d=128
|overall_frequency=0.335938
|n_genomes=27
|n_genomes_annotated=0
|n_haplomes=33
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}